ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

KZIA Kazia Therapeutics Ltd

0.3887
0.01875 (5.07%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Kazia Therapeutics Ltd KZIA NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.01875 5.07% 0.3887 06:25:32
始値 安値 高値 終値 前日終値
0.3646 0.357 0.389 0.37 0.36995
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2121:52PRNUSKazia Therapeutics licenses paxalisib to Sovargen for..
2024/3/1321:00PRNUSKazia announces presentation of new data at AACR Annual..
2024/2/2206:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/2123:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2121:30PRNUSKazia Therapeutics Reports Early Conclusion of Clinical..
2024/2/1505:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1308:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0614:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/0606:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/1906:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/1821:30PRNUSKAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS
2024/1/1306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1607:26EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/12/0622:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0608:02PRNUSKazia Therapeutics Announces Closing of $2 Million..
2023/12/0506:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/0122:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0122:00PRNUSKazia Therapeutics Announces $2 Million Registered Direct..
2023/11/3006:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/3006:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2921:01PRNUSKAZIA ANNOUNCES NON-BINDING LETTER OF INTENT FOR THE..
2023/11/2121:30PRNUSKAZIA PROVIDES OVERVIEW OF PAXALISIB RELATED PRESENTATIONS..
2023/11/2106:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2106:30PRNUSKAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION
2023/11/1523:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1522:30PRNUSKAZIA ANNOUNCES THE RELEASE OF PNOC022 CLINICAL STUDY..
2023/11/1021:01PRNUSKAZIA ANNOUNCES PUBLICATION IN MOLECULAR CANCER THERAPEUTICS..
2023/11/0205:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0120:01PRNUSKAZIA THERAPEUTICS PROVIDES PRELIMINARY UPDATE FROM ONGOING..
2023/10/2620:56EDGAR2Form 20-F - Annual and transition report of foreign private..
2023/10/2321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2320:01PRNUSKAZIA THERAPEUTICS ANNOUNCES CLINICAL DATA AT ESMO 2023 FROM..
2023/10/1405:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1120:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1120:01PRNUSKazia announces voluntary delisting from ASX
2023/10/1104:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0620:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0520:01PRNUSKAZIA THERAPEUTICS ANNOUNCES PRESENTATIONS AT UPCOMING..
2023/9/2920:01PRNUSKAZIA THERAPEUTICS ANNOUNCES ACCEPTANCE OF LATE-BREAKING..
2023/9/2920:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0520:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1120:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/0705:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/0620:00PRNUSKAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA..
2023/6/0820:00PRNUSKAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO..
2023/5/2520:01PRNUSKAZIA CEO, DR. JOHN FRIEND TO PARTICIPATE IN WHITE HOUSE..

最近閲覧した銘柄

Delayed Upgrade Clock